Most rashes that appear during lamotrigine (Lamictal) treatment are mild, allergic-type skin reactions that look like flat, reddish spots spread across the trunk and limbs, and they tend to fade within days of stopping the medication. In a study of nearly a thousand patients, roughly one in eighteen developed a rash attributed to lamotrigine, but only one case qualified as probable Stevens-Johnson syndrome, and none required hospitalization for the rash itself.1PubMed. Predictors of Lamotrigine-associated rash That said, the reason Lamictal rash gets so much attention is the small but real possibility of a life-threatening skin reaction, and telling the two apart early is what matters most.
What the Typical Rash Looks Like
The common lamotrigine rash is what dermatologists call a morbilliform eruption, which just means it resembles a measles-like pattern of small, flat or slightly raised reddish spots. It usually appears on the chest, back, and arms before spreading outward, and the skin between the spots looks normal. It is not blistered, not painful, and not accompanied by fever or mouth sores. This type of rash is allergic in nature and considered benign. It tends to disappear within a few days after the medication is stopped.2The Nurse Practitioner. Lamotrigine rash: Benign allergy or severe adverse reaction?
For many people, the rash amounts to a mild nuisance. It may itch somewhat, and you might notice it first on the torso before seeing scattered spots on the extremities. The key reassurance is the absence of other symptoms. If you feel fine otherwise and the spots are flat and painless, the rash is almost certainly the common variety. That does not mean you should ignore it or keep taking the medication without calling your prescriber, but it does mean you are very unlikely to be facing an emergency.
When Rashes Typically Appear
Lamotrigine rashes overwhelmingly appear during the first few weeks of treatment. The typical window is between five days and eight weeks after starting the drug.2The Nurse Practitioner. Lamotrigine rash: Benign allergy or severe adverse reaction? If you have been on a stable dose for months without skin problems and then develop a rash, it is less likely to be lamotrigine-related, though dose changes can reset the clock. A dose increase that happens too quickly can trigger a rash even after an uneventful initial period.
The timing matters because it helps your clinician figure out whether lamotrigine is really the culprit. If a rash pops up in week two, lamotrigine sits at the top of the suspect list. If it shows up six months into therapy with no recent dose change, your doctor will look harder at other causes, from viral infections to new laundry detergent.
Warning Signs That a Rash Could Be Dangerous
The feared complications are Stevens-Johnson syndrome (SJS) and its more severe form, toxic epidermal necrolysis (TEN). These are rare but genuine medical emergencies in which the immune system attacks the skin and mucous membranes. A systematic review of lamotrigine-induced SJS case reports found that typical features include mucocutaneous lesions (sores in the mouth, eyes, or genital area), skin that starts to peel or detach, fever, and conjunctivitis.3PubMed. Lamotrigine-induced Stevens-Johnson syndrome: a systematic review of case reports and case series One published case described a 25-year-old woman who developed a rash and fever ten days after starting lamotrigine; she had targetoid (bulls-eye-shaped) macules on her chest and limbs with blistering on top and oral mucositis, and required intravenous immunoglobulin and 16 days of hospital care.4Journal of the American Academy of Dermatology. Response: “Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation—A retrospective chart review”
The practical checklist for when to seek urgent medical attention includes any of the following alongside a new rash:
- Mucosal involvement: Sores, blisters, or painful erosions inside the mouth, on the lips, around the eyes, or in the genital area.
- Skin tenderness or pain: The rash hurts when touched rather than just itching mildly.
- Blistering or peeling: Any area where the skin lifts, blisters form, or sheets of skin come away.
- Fever: Temperature elevation, especially when it arrives alongside or just before the rash.
- Facial and upper-body concentration: Serious drug rashes tend to be widespread and prominently involve the face, neck, and upper trunk.
- Hemorrhagic appearance: Spots that look purplish or bruise-like and do not turn white when you press on them.
Serious drug rashes tend to be widespread, with prominent involvement of the face, neck, and upper trunk, and they may be tender or hemorrhagic and fail to blanch with pressure.5The Nurse Practitioner. Lamotrigine rash: Benign allergy or severe adverse reaction? – Section: Implications for practice If any of these features are present, stop the medication and go to an emergency department. Do not wait to see whether the rash improves on its own.
DRESS Syndrome, the Other Severe Reaction
SJS and TEN get most of the headlines, but lamotrigine can also trigger a separate condition called DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). DRESS is a delayed hypersensitivity reaction that combines a widespread skin eruption with fever, swollen lymph nodes, and damage to internal organs.6PubMed Central. Lamotrigine induced DRESS syndrome In a review of 57 patients who developed DRESS from lamotrigine, multisystem involvement was present in over 97% of cases, with the most common features being fever, rash, liver involvement, elevated eosinophils, and swollen lymph nodes.7PubMed. Lamotrigine induced DIHS/DRESS: Manifestations, treatment, and outcome in 57 patients
DRESS rash has a distinctive look compared to the benign morbilliform rash. It typically starts as a maculopapular eruption covering the trunk and limbs but then coalesces into large confluent patches of redness. Facial swelling is considered a hallmark of the condition. The lesions can take many forms, from raised plaques to purplish spots to blistering patches, and cutaneous involvement covers more than half the body surface area. Skin manifestations appear in an estimated 73% to 100% of DRESS cases.8Frontiers in Medical Case Reports. Lamotrigine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Masquerading as A Systemic Autoimmune Process – Section: Discussion
The internal-organ part is what makes DRESS especially dangerous. Liver injury is the most common form of organ damage, and it can actually precede the skin eruption, meaning blood tests might flag a problem before the rash is obvious. Kidney involvement, lung inflammation, and heart inflammation (myocarditis) are also documented, though less frequent.8Frontiers in Medical Case Reports. Lamotrigine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Masquerading as A Systemic Autoimmune Process – Section: Discussion DRESS tends to appear later than SJS, sometimes two to eight weeks into treatment, and it can initially be mistaken for an infection because fever and malaise are the first symptoms. The combination of widespread rash plus feeling systemically unwell (not just itchy) is the red flag that sets DRESS apart from a benign drug rash.
Who Faces a Higher Risk
Several factors make a serious lamotrigine rash more likely, and most of them are things your prescriber should be managing from the start.
Dosing Speed
The single biggest modifiable risk factor is how quickly the dose is increased. In one study of lamotrigine for mood disorders, a fast titration schedule raised the odds of developing a rash by roughly eight times compared to a standard schedule. Slow titration cut the risk significantly.9PubMed Central. Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine for the Treatment of Mood Disorders This is why lamotrigine is started at a low dose and increased gradually over several weeks. It can feel frustratingly slow when you are waiting for the drug to reach a therapeutic level, but the titration schedule exists specifically to reduce the chance of a dangerous skin reaction. If you are tempted to take extra pills to speed things along, don’t.
Valproic Acid Co-Use
Taking valproic acid (Depakote, Depakene) at the same time as lamotrigine roughly triples the odds of developing a rash.9PubMed Central. Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine for the Treatment of Mood Disorders Valproic acid slows lamotrigine’s clearance from the body by interfering with the enzyme pathway that breaks it down, effectively doubling or more the drug’s blood level at any given dose.10PubMed Central. Lamotrigine-Valproic Acid Interaction Leading to Stevens-Johnson Syndrome When the two drugs are combined, prescribers are supposed to use an even slower titration schedule and half the usual target dose. If your provider does not seem aware that you are on valproic acid, bring it up yourself.
Sex and Age
Female sex was associated with about a threefold increase in rash risk in the same mood-disorder study.9PubMed Central. Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine for the Treatment of Mood Disorders Children also appear to face a higher rate of serious rash than adults. Clinical trial data showed that the rate of rash-related hospitalization was about 1.0% in pediatric patients compared to 0.3% in adults, and possible SJS occurred at 0.5% in children versus 0.1% in adults. The difference may be partly explained by dosing practices and higher rates of valproic acid co-use in children during those trials.11Canadian Journal of Neurological Sciences. Rash in Adult and Pediatric Patients Treated with Lamotrigine
An added wrinkle in children is that rashes during lamotrigine treatment are not always caused by the drug. A retrospective study found that concurrent infections appeared to explain some skin symptoms in pediatric patients, and rashes attributed to other causes were considerably more common in children than adults.12PubMed. Rash during lamotrigine treatment is not always drug hypersensitivity: A retrospective cohort study among children and adults That means a child on lamotrigine who develops a rash during an ear infection or a cold needs careful clinical judgment, not an automatic assumption that the drug is responsible. The flip side is that dismissing a rash as viral when it is actually drug-related can be dangerous, so erring on the side of caution and contacting the prescriber remains the right call.
Genetic Background
Certain immune-system gene variants make a person more susceptible to serious lamotrigine skin reactions. The most studied is HLA-B*1502, an allele found most often in people of Southeast Asian descent. A systematic review and meta-analysis found that carrying HLA-B*1502 roughly tripled the odds of developing lamotrigine-induced SJS or TEN.13PubMed. Genetic predisposition for the development of lamotrigine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis A separate meta-analysis in Asian populations confirmed this association in Chinese patients and identified HLA-A*2402 as another risk allele for both SJS/TEN and the milder morbilliform rash.14PubMed. Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: A meta-analysis A separate meta-analysis also confirmed a roughly doubled risk of cutaneous reactions among HLA-A*24:02 carriers across broader populations.15PubMed Central. HLA-A∗24:02 associated with lamotrigine-induced cutaneous adverse drug reactions: A systematic review and meta-analysis
In some countries, genetic testing for HLA-B*1502 is recommended before starting carbamazepine (a related antiepileptic) in patients of Southeast Asian ancestry, and the same logic extends to lamotrigine in certain clinical guidelines. If you are of Han Chinese, Thai, Malaysian, Filipino, or related ancestry and your prescriber does not mention genetic testing, it is reasonable to ask about it. That said, these alleles increase risk but are not destiny. Plenty of carriers never develop a rash, and people without these alleles can still have serious reactions.
Why Lamotrigine Causes Rashes in the First Place
The mechanism is not completely pinned down, but research has pointed to a metabolic pathway involving sulfotransferase enzymes. When the body processes lamotrigine, one of its breakdown products, lamotrigine-N-oxide, gets converted by sulfotransferases into a chemically reactive sulfate compound. This reactive metabolite can bind to proteins in the skin and potentially trigger the immune system to attack those modified proteins as foreign.16ACS Publications (Chemical Research in Toxicology). Potential Involvement of Sulfotransferase in the Mechanism of Lamotrigine-induced Skin Rash The interaction between this metabolic quirk and an individual’s immune genetics likely explains why only some people react and why the severity varies so much.
This also helps explain why slow dose titration is protective. A gradual increase gives the immune system time to develop tolerance to small amounts of the reactive metabolite rather than encountering a large dose of it all at once. It is a bit like easing into a hot bath instead of jumping in.
What to Do If You Develop a Rash
Any new rash during lamotrigine treatment, especially in the first two months, warrants a call to your prescriber the same day. If the rash is accompanied by fever, mouth sores, skin blistering, facial swelling, or you feel generally unwell, go to an emergency department rather than waiting for a callback. Most prescribers will tell you to stop lamotrigine immediately and will want to examine the rash in person or see photos. Even if the rash turns out to be benign, stopping the drug early is far safer than continuing it through what might be the opening stage of SJS.
One point that catches some people off guard: not every rash that shows up during lamotrigine treatment is caused by lamotrigine. Viral exanthems, contact dermatitis, and other coincidental skin problems can happen at the same time. But from a safety standpoint, it is nearly always better to stop the medication first, sort out the cause second, and discuss restarting later once a clinician has ruled out a drug reaction.
Trying Lamotrigine Again After a Rash
For people whose seizures or mood disorder responded well to lamotrigine, losing the drug to a mild rash is a frustrating outcome. Rechallenge, meaning restarting lamotrigine after a previous rash, is a real option if the initial rash was benign. A prospective case series combined with a meta-analysis of prior reports found a pooled success rate of about 85% when patients who had developed a rash were rechallenged with lamotrigine. No patients developed SJS or TEN during rechallenge.17PubMed Central. Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature
Timing and approach matter. The same study found that starting rechallenge within four weeks of the initial rash carried a much higher rate of a second rash compared to waiting longer. In numbers, the rash rate was 36% for early rechallenge versus 7% when patients waited more than four weeks.17PubMed Central. Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature The rechallenge protocol itself used an extremely slow titration, starting at just 5 mg every other day for two weeks before creeping upward in tiny increments, which is even more conservative than the standard starting schedule.17PubMed Central. Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature
Rechallenge is generally considered viable after a clearly benign rash and can be undertaken with more caution even after rashes with one or two signs of potential seriousness.18Revista de Psiquiatría y Salud Mental (English Edition). Lamotrigine rechallenge after a skin rash. A combined study of open cases and a meta-analysis However, rechallenge after confirmed SJS, TEN, or DRESS is a different question entirely and is generally avoided. If the initial reaction was serious, the risk of a potentially fatal recurrence is too high to justify.
Rashes That Are Not What They Seem
Because lamotrigine’s rash reputation precedes it, there is a real risk of overcorrection, where any skin change during treatment triggers a panic that may not be warranted. A retrospective study looking at both children and adults on lamotrigine found that about 7% reported skin symptoms within the first three months, but only about 5% of the total patient group had reactions that were classified as probable drug-related rashes. Among children specifically, other skin rashes (those linked to concurrent infections or unrelated causes) were significantly more common than in adults.12PubMed. Rash during lamotrigine treatment is not always drug hypersensitivity: A retrospective cohort study among children and adults
This is clinically relevant because an unnecessary discontinuation can leave a person without a medication that was controlling their seizures or stabilizing their mood. The ideal response is always to have the rash evaluated by a clinician who can look at its distribution, check for mucosal involvement, review bloodwork if warranted, and make a judgment call rather than to stop the drug in isolation and never revisit the question. The stakes run in both directions: continuing lamotrigine through a genuine drug reaction is dangerous, but abandoning an effective medication for a coincidental rash is also a real loss.